These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 28561682)

  • 1. Advances in the Treatment of Advanced Extracutaneous Melanomas and Nonmelanoma Skin Cancers.
    Komatsubara KM; Jeter J; Carvajal RD; Margolin K; Schadendorf D; Hauschild A
    Am Soc Clin Oncol Educ Book; 2017; 37():641-650. PubMed ID: 28561682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-Melanoma Skin Cancers: Biological and Clinical Features.
    Cives M; Mannavola F; Lospalluti L; Sergi MC; Cazzato G; Filoni E; Cavallo F; Giudice G; Stucci LS; Porta C; Tucci M
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Programmed cell death 1 protein and programmed death-ligand 1 inhibitors in the treatment of nonmelanoma skin cancer: A systematic review.
    Choi FD; Kraus CN; Elsensohn AN; Carley SK; Lehmer LM; Nguyen RT; Linden KG; Shiu J
    J Am Acad Dermatol; 2020 Feb; 82(2):440-459. PubMed ID: 31163235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Updates in the Management of Advanced Nonmelanoma Skin Cancer.
    Yan F; Schmalbach CE
    Surg Oncol Clin N Am; 2024 Oct; 33(4):723-733. PubMed ID: 39244290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Landmark Series: Non-melanoma Skin Cancers.
    Lee AY; Berman RS
    Ann Surg Oncol; 2020 Jan; 27(1):22-27. PubMed ID: 31549317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular pathology of skin neoplasms of the head and neck.
    Kraft S; Granter SR
    Arch Pathol Lab Med; 2014 Jun; 138(6):759-87. PubMed ID: 24878016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PD-1 inhibition in advanced Merkel-cell carcinoma.
    Baker H
    Lancet Oncol; 2016 Jun; 17(6):e225. PubMed ID: 27132870
    [No Abstract]   [Full Text] [Related]  

  • 8. Divergent response to PD-L1 inhibition in advanced Merkel cell carcinoma and cutaneous squamous cell carcinoma.
    Salzmann M; Löser C; Hassel JC
    J Dtsch Dermatol Ges; 2023 Jul; 21(7):803-805. PubMed ID: 37066606
    [No Abstract]   [Full Text] [Related]  

  • 9. Differential BMI1, TWIST1, SNAI2 mRNA expression pattern correlation with malignancy type in a spectrum of common cutaneous malignancies: basal cell carcinoma, squamous cell carcinoma, and melanoma.
    Vand-Rajabpour F; Sadeghipour N; Saee-Rad S; Fathi H; Noormohammadpour P; Yaseri M; Hesari KK; Bagherpour Z; Tabrizi M
    Clin Transl Oncol; 2017 Apr; 19(4):489-497. PubMed ID: 27718152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cytokines: current status and prospects in the treatment of skin tumors].
    Nashan D; Luger TA
    Hautarzt; 2001 Aug; 52(8):691-6. PubMed ID: 11544938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic Therapy for Non-Melanoma Skin Cancers: Latest Advances.
    Lessans S; O'Connell KA; Choe J
    Curr Oncol Rep; 2024 Sep; 26(9):1120-1133. PubMed ID: 38954315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cutaneous neoplasms].
    Dummer R; Beyeler M; Morcinek J; Burg G
    Praxis (Bern 1994); 2003 Sep; 92(36):1470-8. PubMed ID: 14526630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The molecular genetics of eyelid tumors: recent advances and future directions.
    Milman T; McCormick SA
    Graefes Arch Clin Exp Ophthalmol; 2013 Feb; 251(2):419-33. PubMed ID: 23275038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical management of cutaneous malignancies.
    Gibbs P; Gonzalez R; Lee LA; Walsh P
    Clin Dermatol; 2001; 19(3):298-304. PubMed ID: 11479042
    [No Abstract]   [Full Text] [Related]  

  • 15. Critical skin cancer in organ transplant recipients--a dermatopathological view.
    Kempf W; Mertz KD; Kanitakis J; Hofbauer GF
    Curr Probl Dermatol; 2012; 43():18-35. PubMed ID: 22377917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-Risk Non-Melanoma Skin Cancers: Biological and Therapeutic Advances.
    Lee T; Oka T; Demehri S
    Hematol Oncol Clin North Am; 2024 Oct; 38(5):1071-1085. PubMed ID: 38908957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy for Nonmelanoma Skin Cancer: Facts and Hopes.
    Shalhout SZ; Kaufman HL; Emerick KS; Miller DM
    Clin Cancer Res; 2022 Jun; 28(11):2211-2220. PubMed ID: 35121622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin cancer in organ transplant recipients.
    Kempf W; Mertz KD; Hofbauer GF; Tinguely M
    Pathobiology; 2013; 80(6):302-9. PubMed ID: 24013135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Responses of metastatic basal cell and cutaneous squamous cell carcinomas to anti-PD1 monoclonal antibody REGN2810.
    Falchook GS; Leidner R; Stankevich E; Piening B; Bifulco C; Lowy I; Fury MG
    J Immunother Cancer; 2016; 4():70. PubMed ID: 27879972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal treatment of unresectable nonmelanoma skin cancers.
    Olencki T
    J Natl Compr Canc Netw; 2014 May; 12(5 Suppl):789-92. PubMed ID: 24853218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.